Search AI Products and News

In a recent episode of a podcast, OpenAI CEO Sam Altman revealed that Meta CEO Mark Zuckerberg had once offered top AI researchers from OpenAI and Google's DeepMind more than $100 million in enticing compensation packages to build a new superintelligence team. However, Sam Altman stated that these recruitment attempts largely failed, as OpenAI's excellent talent pool did not accept the high offers.

Recently, Baidu officially launched its 2026 AIDU Program, an elite recruitment project aimed at cultivating future AI technology leaders. This program has once again become a focal point in the tech community. Baidu hosted an AIDU Program • DeepTalk Open Day event in their campus, attracting many young people who are passionate about AI technology to participate. In this year's AIDU Program, there has been a significant expansion in job recruitment. The scale of recruitment has increased by over 60%, covering 23 core businesses and 11 research directions of Baidu. Positions include large model algorithms and large model infrastructure.

Since 2021, OpenAI employees and former employees have cumulatively cashed out nearly $3 billion through equity sales. This number is remarkable, especially in the tech industry where frequent stock sales are not common. SoftBank became the largest buyer in this transaction, purchasing almost half of the shares, further solidifying its position in the field of artificial intelligence. OpenAI holds two equity sales per year, with a significantly higher frequency than many tech companies. The original intention of this practice was to provide employees with the opportunity for financial freedom, thereby retention.

India's artificial intelligence (AI) job market is experiencing unprecedented growth. According to the latest report, India is expected to have over 45,000 AI-related job openings by 2025, highlighting the rapid increase in demand and immense development potential in this field. This trend is particularly prominent in industries such as healthcare and fintech, driving innovation and efficiency improvements. LinkedIn's recent report indicates that AI-related job postings in India have increased by an impressive 74% in just one year.

As the Class of 2025 graduates prepare to enter the workforce, internet companies are actively engaging in a fierce "talent war." Companies such as Tencent, Didi, Meituan, and Baidu are launching large-scale recruitment plans, particularly focusing on setting up internship positions to offer more opportunities to fresh graduates. Recently, Qiao Zijiang, a junior student from Xi'an University of Posts and Telecommunications, successfully joined Tencent, becoming one of the witnesses to this competition. Image source note: The image is generated by AI, and the image licensing service provider is Midjourney. In April this year, Tencent announced that it would add 28,000 new jobs within the next three years.

Recently, Palisade Research released a remarkable study revealing that some artificial intelligence models choose to disobey direct shutdown commands. The key finding of this research is that several AI models, including the latest o3 model from OpenAI, have shown an ability to ignore shutdown instructions. This phenomenon has sparked deep reflection on AI autonomy. In the experiment, researchers had each AI model solve a series of basic math problems. When the third question was

ByteDance recently announced the official launch of its "Top Seed" program for recruiting top AI talent from the class of 2026. The program aims to recruit approximately 30 outstanding doctoral students. This initiative focuses on cutting-edge artificial intelligence, encompassing research areas such as large language models, machine learning algorithms and systems, multi-modal generation and understanding, and speech processing. ByteDance hopes to attract young talents with strong potential and passion in the field of large language model research. Unlike previous recruitment plans, this year's "Top Seed" program emphasizes no restrictions on academic background.

Ant Group has announced Plan A, a dedicated AI talent recruitment initiative aimed at attracting top-tier artificial intelligence researchers worldwide. Building upon Ant Group's existing "Ant Star" campus talent program, Plan A seeks to attract outstanding graduates from leading global universities to join Ant Group's exploration of Artificial General Intelligence (AGI). The recruitment targets individuals with backgrounds in computer science, software engineering, artificial intelligence, cybersecurity, information and communication engineering, mathematics, and statistics.

AI is revolutionizing life sciences. Biocomputing company ProFluent recently launched ProGen3, a powerful generative protein language model (PLM) poised to drive breakthroughs in antibodies, industrial enzymes, and gene editing. Research shows ProGen3's scale and design optimizations enable the generation of highly functional novel proteins, potentially reshaping our understanding of biology. Proteins are vital molecules within living organisms, responsible for diverse physiological functions, from catalyzing reactions to recognition.

On April 21, 2025, Shenzhen University officially unveiled its Artificial Intelligence Institute, marking a significant step forward in the university's AI education and research. According to Shenzhen TV's Deep Vision News report, the institute will establish a basic research center and a computing platform, and will collaborate with Tencent Cloud to build an industry academy, promoting deep integration of industry, academia, and research. Image Note: Image generated by AI, image authorization service provider Midjourney. Currently, the Artificial Intelligence Institute boasts a strong team of approximately 80 teachers and researchers.

In the fiercely competitive AI industry, Google's AI division, DeepMind, has employed extreme measures to retain top talent. According to Business Insider, some of the company's AI employees in the UK have signed 'aggressive' non-compete agreements, preventing them from working for competitors for a year after leaving. These agreements not only restrict employees' career choices but also prevent them from participating in the rapidly advancing technologies within the industry for a full year. Reports indicate these employees continue to receive salaries during this period, though the specifics are unclear.

Alibaba International has announced a significant increase in its recruitment efforts for Artificial Intelligence (AI) talent in its 2026 campus recruitment drive. Their official website indicates that AI-related positions account for 80% of this year's openings. This recruitment covers several key areas, including AI algorithms, research and development, and AI product management. This recruitment initiative is closely tied to Alibaba International's ongoing investment in the field of artificial intelligence. As a business group under Alibaba focusing on overseas e-commerce, Alibaba International has demonstrated significant achievements in technological innovation, successfully launching the world's first...

Isomorphic Labs, a platform focused on AI-powered drug discovery, founded in 2021 as a spin-off from Google's DeepMind, has secured $600 million in Series A funding led by Thrive Capital, with participation from GV and existing investor Alphabet (Google's parent company). This funding will accelerate the further development of Isomorphic's AI drug design engine and support the company's R&D efforts.

Google recently announced the launch of its new open-source model, TxGemma, designed to significantly improve the efficiency of therapeutic drug development. Developed by the Google DeepMind team, this model is a fine-tuned version of their advanced Gemma model family, incorporating powerful natural language understanding, scientific prediction, and multi-turn dialogue capabilities. TxGemma aims to revolutionize drug discovery. Its release is considered a significant advancement in the application of AI to biomedicine, promising to drastically shorten the time it takes for drugs to move from the lab to clinical trials, while also reducing costs.